Free Access
Issue
Med Sci (Paris)
Volume 29, Number 8-9, Août–Septembre 2013
Page(s) 722 - 728
Section Diabète : approches thérapeutiques émergentes
DOI https://doi.org/10.1051/medsci/2013298010
Published online 05 September 2013
  1. Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010 ; 10 : 501–513. [CrossRef] [PubMed] [Google Scholar]
  2. Diana J, Simoni Y, Furio L, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013 ; 19 : 65–73. [CrossRef] [PubMed] [Google Scholar]
  3. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007 ; 25 : 297–336. [CrossRef] [PubMed] [Google Scholar]
  4. Simoni Y, Diana J, Ghazarian L, et al. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol 2013 ; 171 : 8–19. [CrossRef] [PubMed] [Google Scholar]
  5. Gombert JM, Herbelin A, Tancrede-Bohin E, et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 1996 ; 26 : 2989–2998. [CrossRef] [PubMed] [Google Scholar]
  6. Hammond KJ, Pellicci DG, Poulton LD, et al. CD1d-restricted NKT cells: an interstrain comparison. J Immunol 2001 ; 167 : 1164–1173. [PubMed] [Google Scholar]
  7. Lehuen A, Lantz O, Beaudoin L, et al. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998 ; 188 : 1831–1839. [CrossRef] [PubMed] [Google Scholar]
  8. Falcone M, Facciotti F, Ghidoli N, et al. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immunol 2004 ; 172 : 5908–5916. [PubMed] [Google Scholar]
  9. Wang B, Geng YB, Wang CR. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001 ; 194 : 313–320. [CrossRef] [PubMed] [Google Scholar]
  10. Shi FD, Flodstrom M, Balasa B, et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc Natl Acad Sci USA 2001 ; 98 : 6777–6782. [CrossRef] [Google Scholar]
  11. Rapoport MJ, Jaramillo A, Zipris D, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993 ; 178 : 87–99. [CrossRef] [PubMed] [Google Scholar]
  12. Laloux V, Beaudoin L, Jeske D, et al. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J Immunol 2001 ; 166 : 3749–3756. [PubMed] [Google Scholar]
  13. Hammond KJ, Poulton LD, Palmisano LJ, et al. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998 ; 187 : 1047–1056. [CrossRef] [PubMed] [Google Scholar]
  14. Chen YG, Choisy-Rossi CM, Holl TM, et al. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol 2005 ; 174 : 1196–1204. [PubMed] [Google Scholar]
  15. Beaudoin L, Laloux V, Novak J, et al. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002 ; 17 : 725–736. [CrossRef] [PubMed] [Google Scholar]
  16. Naumov YN, Bahjat KS, Gausling R, et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA 2001 ; 98 : 13838–13843. [CrossRef] [Google Scholar]
  17. Novak J, Beaudoin L, Park S. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J Immunol 2007 ; 178:1332–1340. [PubMed] [Google Scholar]
  18. Novak J, Beaudoin L, Griseri T, Lehuen A. Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J Immunol 2005 ; 174 : 1954–1961. [PubMed] [Google Scholar]
  19. Michel ML, Keller AC, Paget C, et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007 ; 204 : 995–1001. [CrossRef] [PubMed] [Google Scholar]
  20. Simoni Y, Gautron AS, Beaudoin L, et al. NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes. Eur J Immunol 2011 ; 41 : 3574–3585. [CrossRef] [PubMed] [Google Scholar]
  21. Wilson SB, Kent SC, Patton KT, et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998 ; 391 : 177–181. [CrossRef] [PubMed] [Google Scholar]
  22. Kis J, Engelmann P, Farkas K, et al. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J Leukoc Biol 2007 ; 81 : 654–662. [CrossRef] [PubMed] [Google Scholar]
  23. Kent SC, Chen Y, Clemmings SM, et al. Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J Immunol 2005 ; 175 : 4458–4464. [PubMed] [Google Scholar]
  24. Diana J, Brezar V, Beaudoin L, et al. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J Exp Med 2011 ; 208 : 729–745. [CrossRef] [PubMed] [Google Scholar]
  25. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988 ; 239 : 500–502. [CrossRef] [PubMed] [Google Scholar]
  26. Diana J, Griseri T, Lagaye S, et al. NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 2009 ; 30 : 289–299. [CrossRef] [PubMed] [Google Scholar]
  27. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001 ; 7 : 1057–1062. [CrossRef] [PubMed] [Google Scholar]
  28. Wang J, Cho S, Ueno A, et al. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation. J Immunol 2008 ; 181 : 2438–2445. [PubMed] [Google Scholar]
  29. Blumenfeld HJ, Tohn R, Haeryfar SM, et al. Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol 2011 ; 166 : 121–133. [CrossRef] [PubMed] [Google Scholar]
  30. Ghazarian L, Diana J, Simoni Y, et al. Prevention or acceleration of type 1 diabetes by viruses. Cell Mol Life Sci 2013 ; 70 : 239–255. [CrossRef] [PubMed] [Google Scholar]
  31. Motohashi S, Ishikawa A, Ishikawa E, et al. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2006 ; 12 : 6079–6086. [CrossRef] [PubMed] [Google Scholar]
  32. Brennan PJ, Tatituri RV, Brigl M, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011 ; 12 : 1202–1211. [CrossRef] [PubMed] [Google Scholar]
  33. Hegde S, Lockridge JL, Becker YA, et al. Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands. J Autoimmun 2011 ; 37 : 28–28. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.